Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001214659-25-018593
Filing Date
2025-12-30
Accepted
2025-12-30 12:47:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 y1230250dfan14a.htm DFAN14A 15207
  Complete submission text file 0001214659-25-018593.txt   17103
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 900 BRISBANE CA 94005 650-242-8052
Pacira BioSciences, Inc. (Subject) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-35060 | Film No.: 251612867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3350 VIRGINIA STREET SUITE 530 MIAMI FL 33133
Business Address 3350 VIRGINIA STREET SUITE 530 MIAMI FL 33133 13055495081
Doma Perpetual Capital Management LLC (Filed by) CIK: 0001962221 (see all company filings)

EIN.: 880868808 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A